(Q43694222)

English

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate (English)

1 reference

Europe PubMed Central

25 November 2017

phase III clinical trial

0 references

radiation therapy

0 references

author name string

Pilepich MV

1

1 reference

Europe PubMed Central

25 November 2017

Winter K

2

1 reference

Europe PubMed Central

25 November 2017

John MJ

3

1 reference

Europe PubMed Central

25 November 2017

Mesic JB

4

1 reference

Europe PubMed Central

25 November 2017

Sause W

5

1 reference

Europe PubMed Central

25 November 2017

Rubin P

6

1 reference

Europe PubMed Central

25 November 2017

Lawton C

7

1 reference

Europe PubMed Central

25 November 2017

Machtay M

8

1 reference

Europe PubMed Central

25 November 2017

Grignon D

9

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

25 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

25 November 2017

50

1 reference

Europe PubMed Central

25 November 2017

1243-1252

1 reference

Europe PubMed Central

25 November 2017

5

1 reference

Europe PubMed Central

25 November 2017

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal treatment before radical prostatectomy: a 3-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Tr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901579-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)01579-6

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43694222&oldid=2102630865"